Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


11.11.2024

1 BMC Neurol
3 Exp Neurol
2 J Biol Chem
3 Mov Disord
1 Nat Rev Neurol
1 Neurobiol Dis
2 Neuroscience
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. AIELLO EN, Solca F, Torre S, Curti B, et al
    Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.
    BMC Neurol. 2024;24:427.
    PubMed         Abstract available


    Exp Neurol

  2. SERRA M, Faustini G, Brembati V, Casu MA, et al
    Early alpha-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease.
    Exp Neurol. 2024 Nov 3:115040. doi: 10.1016/j.expneurol.2024.115040.
    PubMed         Abstract available

  3. LI Z, Luo J, Li C, Zhu H, et al
    Upregulation of Nav1.6 expression in the ventral posterolateral nucleus of thalamus contributes to hyperalgesia in a model of Parkinson's disease.
    Exp Neurol. 2024 Oct 25:115032. doi: 10.1016/j.expneurol.2024.115032.
    PubMed         Abstract available

  4. ZHONG J, Yu X, Zhong Y, Tan L, et al
    GSK-3beta inhibitor amplifies autophagy-lysosomal pathways by regulating TFEB in Parkinson's disease models.
    Exp Neurol. 2024 Oct 25:115033. doi: 10.1016/j.expneurol.2024.115033.
    PubMed         Abstract available


    J Biol Chem

  5. QIAO Y, Kou J, Tian Y, Ma W, et al
    Subcellular localization and function analysis of PINK1 mitron in PD progression: Mitron modulates mitochondrial morphology to regulate neuronal death.
    J Biol Chem. 2024;300:107773.
    PubMed         Abstract available

  6. BAYATI A, McPherson PS
    Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions.
    J Biol Chem. 2024;300:107742.
    PubMed         Abstract available


    Mov Disord

  7. HWANG YS, Jo S, Lee SH, Park KW, et al
    Identification of Novel Genetic Loci Affecting Age at Onset of Parkinson's Disease: A Genome-wide Association Study.
    Mov Disord. 2024 Nov 6. doi: 10.1002/mds.30047.
    PubMed         Abstract available

  8. ZAGARE A, Hemedan A, Almeida C, Frangenberg D, et al
    Insulin Resistance Is a Modifying Factor for Parkinson's Disease.
    Mov Disord. 2024 Nov 5. doi: 10.1002/mds.30039.
    PubMed         Abstract available

  9. VAZIRIAN F, Tian J, Jane Alty, Aitken D, et al
    Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13-Year Longitudinal Study.
    Mov Disord. 2024 Nov 2. doi: 10.1002/mds.30046.
    PubMed         Abstract available


    Nat Rev Neurol

  10. STOCCHI F, Bravi D, Emmi A, Antonini A, et al
    Parkinson disease therapy: current strategies and future research priorities.
    Nat Rev Neurol. 2024 Nov 4. doi: 10.1038/s41582-024-01034.
    PubMed         Abstract available


    Neurobiol Dis

  11. LAI MS, Sorensen MH, Lee K, Chu JM, et al
    3D mapping of direct VTA-CA2 circuit with potential involvement in Parkinson's disease degeneration.
    Neurobiol Dis. 2024;202:106723.
    PubMed         Abstract available


    Neuroscience

  12. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
    Corrigendum to "Assessing the location, relative expression and subclass of dopamine receptors in the cerebellum of hemi-parkinsonian rats" [Neuroscience 521 (2023) 1-19].
    Neuroscience. 2024 Oct 25:S0306-4522(24)00561.
    PubMed        

  13. YUAN J, Dong X, Zhou S, Nao J, et al
    Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review.
    Neuroscience. 2024 Nov 1:S0306-4522(24)00565.
    PubMed         Abstract available


    Rev Neurol (Paris)

  14. MAGDY R, Mohammed Z, Hassan A, Ali M, et al
    Validation of the Arabic version of Parkinson's Disease Sleep Scale-Revised Version (PDSS-2).
    Rev Neurol (Paris). 2023 Oct 26:S0035-3787(23)01082.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.